watch
Baxter International, Inc.

Baxter International, Inc.

Sector: Biological Products Except Diagnostic Substances Region: IL, United States


: | SIX Swiss Exchange: BAX | New York Stock Exchange: BAX


Similar to: ALLENEX AB, BioTime, Inc., NPS Pharmaceuticals, Inc.

Baxter International, Inc. develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions through its subsidiaries. It applies a combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. It operates business through two segments: BioScience and Medical Products. The BioScience segment processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; biosurgery products; and select vaccines. The Medical Products segment manufactures intravenous IV solutions and administration sets, premixed drugs and drug-reconstitution systems, prefilled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, and inhalation anesthetics. The business also provides products and services related to pharmacy compounding, drug formulation and packaging technologies. In addition, the Medical Products business provides products and services to treat end-stage renal disease, or irreversible kidney failure. It also manufactures solutions and other products for peritoneal dialysis, a home-based therapy, and also distributes products for hemodialysis, which is generally conducted in a hospital or clinic. Baxter International was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.

Latest Media

Warning! Third-party cookies must be enabled to view SlideShare presentations. ×

Having trouble?

Baxter's Sustainability Initiatives Support Company's Mission

At Baxter, sustainability means creating lasting social, environmental and economic value by addressing the needs of the company's wide-ranging stakeholder base. Baxter's sustainability initiatives support the company's mission to apply innovative science in the development of medical products and specialty therapies that save and sustain patients' lives.

Baxter International, Inc. video

Baxter's Sustainability Initiatives Support Company's Mission

Baxter International, Inc. video

Ring The Bell - Baxter International at Stanton Springs

Baxter International, Inc. video

Interview with Baxter Healthcare's Vice President for EHS and Sustainability

Executives

Robert L. Parkinson, Jr., Chairman and Chief Executive Officer
Robert L. Parkinson, Jr. is chairman and chief executive officer of Baxter International Inc.
Prior to joining Baxter in April 2004, Parkinson was dean of Loyola University Chicago’s School of Business Administration and Graduate School of Business. Previously, he had a distinguished 25-year career at Abbott Laboratories, serving in a variety of domestic and international management and leadership positions.
Parkinson joined Abbott in 1976 and held a number of marketing and management positions there before being named vice president of European operations in 1990, president of the chemical and agricultural division in 1993 and president of the international division responsible for pharmaceutical, hospital and nutritional products in 1995. In 1998 he became a member of its board of directors before being named president and chief operating officer of the company in 1999. He retired from Abbott in 2001.
He began his career in 1976 with American Hospital Supply Corporation.
He is active on a variety of industry boards and community organizations. Parkinson serves on the board of directors for Chicago-based Northwestern Memorial HealthCare and serves as chairman of Northwestern Lake Forest Hospital. He also serves on Loyola University Chicago's Board of Trustees and is currently chairman of the board of Junior Achievement of Chicago. Parkinson serves on the boards of Catholic Charities, FIRST (For Inspiration and Recognition of Science and Technology), and is the past chairman of the Executives' Club of Chicago.
Parkinson earned both a bachelor’s degree and a master’s degree in business administration from Loyola University Chicago.
Robert J. Hombach, Chief Financial Officer
Robert J. Hombach is corporate vice president and chief financial officer overseeing Baxter's global financial operations.
Hombach joined Baxter in 1989 and has served in a number of finance positions with increasing responsibility in the planning, manufacturing, operations, and treasury areas. Prior to his current role, he served as corporate vice president and treasurer. Hombach also served as vice president of finance, Europe, and vice president corporate planning and analysis where he led several enterprise-wide initiatives and served as a member of the Baxter strategy team.
Hombach earned his master's degree in business administration from Northwestern University's Kellogg Graduate School of Management, and his bachelor of science in finance, cum laude, from the University of Colorado. He has also earned the Certified Public Accountant (CPA) and Certified Management Accountant (CMA) designations.
David P. Scharf, Corporate Vice Presidentgeneral counsel
Scharf joined Baxter in 2005 and was appointed to his current role in 2009. Previously, Scharf held positions of increasing responsibility at Guidant Corporation and Sears, Roebuck and Co. and was an associate with Baker & Daniels. Scharf received his law degree from the University of Chicago, where he was a member of the law review, and his bachelor's degree in finance from Indiana University. Prior to law school, Scharf worked in foreign exchange derivatives for a predecessor of UBS. Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.

News & Analysis

You may also be interested in: